Features | Partner Sites | Information | LinkXpress
Sign In
FOCUS DIAGNOSTICS, INC.
GLOBETECH PUBLISHING
RANDOX LABORATORIES

Novel Microbes Identified, Linked to Severe Diarrhea

By Labmedica International staff writers
Posted on 09 Jul 2014
454 Life Sciences Genome Sequencer FLX system
454 Life Sciences Genome Sequencer (Photo courtesy of Roche Diagnostics)
Microorganisms have been identified that may trigger diarrheal disease and others that may protect against it, which were not widely linked to the condition previously.

Diarrheal diseases continue to contribute significantly to morbidity and mortality in infants and young children in developing countries and there is an urgent need to better understand the contributions of novel, potentially uncultured, diarrheal pathogens to severe diarrheal disease, as well as distortions in normal gut microbiota composition that might facilitate severe disease.

An international team of scientists led by those at the University of Maryland (College Park, MD, USA) surveyed the intestinal microbiota of 992 children from four under-developed countries in West Africa (The Gambia and Mali), East Africa (Kenya), and South Asia (Bangladesh). Stool samples were selected from a large case/control study of moderate-to-severe diarrhea in children aged less than five years. All samples were analyzed by traditional microbiological tests for known bacterial, viral, and eukaryotic pathogens.

DNA was isolated and extracted using the QIAamp DNA stool extraction kit (Qiagen; Venlo, The Netherlands). DNA was amplified using “universal” primers targeting the V1-V2 region of the 16S ribosomal ribonucleic acid (rRNA) gene, a small subunit of the ribosome, in bacteria. Both forward and reverse primers had a 5’ portion specific for use with FLX sequencing technology (454 Life Sciences; Branford, CT, USA).

The scientists identified statistically significant disease associations with several organisms already implicated in diarrheal disease, such as members of the Escherichia/Shigella genus and Campylobacter jejuni. They also found that organisms not widely believed to cause the disease, including Streptococcus and Granulicatella, correlated with the condition in their study. In addition, the study revealed that the Prevotella genus and Lactobacillus ruminis may play a protective role against diarrhea. In almost 50% of the children examined with diarrhea, the condition could not be attributed to a specific causal pathogen. The team also found numerous children carrying Shigella, which is known to cause problems, yet the children showed no signs of moderate to severe diarrhea.

The authors concluded that their analysis of the 16S rRNA gene-based taxonomic profile of diarrheal and control stool samples demonstrated a strong association between acute diarrheal disease and the overall taxonomic composition of the stool microbiota in young children from the developing world. O. Colin Stine, PhD, a professor and senior author of the study said, “We were able to identify interactions between microbiota that were not previously observed, and we think that some of those interactions may actually help prevent the onset of severe diarrhea.” The study was published on June 27, 2014, in the journal Genome Biology.

Related Links:

University of Maryland
454 Life Sciences




Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
Free digital version edition of LabMedica International sent by email on regular basis
Free print version of LabMedica International magazine
(available only outside USA and Canada).
Free and unlimited access to back issues of LabMedica International in digital format
Free LabMedica International Newsletter sent every 2 weeks containing the latest news
Free breaking news sent via email
Free access to Events Calendar
Free access to LinkXpress new product services
REGISTRATION IS FREE AND EASY!


Click here to Register

Sign in: Registered website members
Username: Password:
Forgot username/password? Click here!
Sign in: Registered magazine subscribers
Subcode: Last Name:
What is SUBCODE?


Sekisui Diagnostics
PURITAN MEDICAL
EUROIMMUN AG
comments powered by Disqus
Life Technologies

Channels

Clinical Chemistry

view channel
Image: Enzyme-linked immunosorbent kit (ELISA) specific for human copeptin (Photo courtesy of USCN Life Science).

Preeclampsia Biomarker Detected Very Early In Pregnancy

A biomarker has been discovered that could give expecting mothers and their doctors the first simple blood test to reliably predict that a pregnant woman may develop preeclampsia, at least as early as... Read more

Pathology

view channel
Image: Glioblastoma multiforme (GBM) (Photo courtesy of the University of California, San Diego School of Medicine).

Brain Tumor Chemotherapy Biomarkers Identified

Cancer researchers have identified a new biomarker that they believe can predict whether glioblastoma multiformes (GBMs), the most common and aggressive type of malignant brain tumor, will be susceptible... Read more

Lab Tech.

view channel
Image:  The Becton Dickinson fluorescent activated cell sorter FACScan (Photo courtesy of the Albert Einstein College of Medicine).

Noninvasive Method Captures Circulating Tumor Cells

A clinically proven, noninvasive fluorescence virus-guided capture system of human colorectal circulating tumor cells (CTCs) from blood samples for genetic testing has been introduced. This noninvasive... Read more

Industry News

view channel

Beckman Coulter Acquires Siemens Healthcare Diagnostics’ Clinical Microbiology Business

Beckman Coulter (Brea, CA, USA), an indirect wholly-owned subsidiary of Danaher Corp. (Washington DC, MD, USA) has entered into a definitive agreement to purchase the clinical microbiology business of Siemens Healthcare Diagnostics (Chicago, IL, USA). The transaction is expected to close in the first quarter of 2015.... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.